• TechCrunch
• CrunchBase
• More
  • TechCrunch UK
  • TechCrunch France
  • TechCrunch Japan

Merck Serono Ventures

edit

Merck Serono Ventures is a strategic, corporate venture capital fund that invests in emerging biotechnology companies. The fund invests in biotech start-up companies that have the potential to provide innovative products in Merck Serono’s core therapeutic areas, in particular in Neurodegenerative Diseases, Oncology, Autoimmune & Inflammatory Diseases, Endocrinology and Fertility. In addition, Merck Serono Ventures invests in companies developing innovative technologies that could enable the discovery and development of new products in Merck Serono’s core therapeutic areas.

Milestones

edit

• 
  Merck Serono Ventures invested in Auxogyn. (2/2/12)
  Posted 2/2/12 at 7:11pm via bizjournals.com
• 
  Merck Serono Ventures invested in f-star Biotech. (4/13/11)
  Posted 7/17/11 at 6:02pm via f-star.com
• 
  Merck Serono Ventures invested in f-star Biotech. (1/6/10)
  Posted 1/6/10 at 8:23pm via f-star.com
• 
  Merck Serono Ventures invested in Ambrx. (4/1/09)
  Posted 4/13/09 at 1:07pm via onbiovc.com
• 
  Merck Serono Ventures invested in Anaphore. (6/9/09)
  Posted 6/16/09 at 10:25am via onbiovc.com

Investments

Videos

Sources

1. Auxogyn raises $20M in Series A funds (bizjournals.com) [edit]
2. f-star raises €15M in a New Financing led by SR One (f-star.com) [edit]
3. f-star raises €8m in an Extended Series A Financing co-led by MP Health-care Venture Management and Merck Serono Ventures (f-star.com) [edit]
4. Anaphore, Inc.: Series A $13M (onbiovc.com) [edit]
5. Ambrx, Inc.: Series D $10M (onbiovc.com) [edit]